iPath Series B S&P 500 V... VXZ - Catena di Opzioni | ADVFN

Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.

Registrati

Home
Investire
Obbligazioni
U.S.A.
AMEX
iPath Series B S&P 500 VIX MidTerm Futures ETN (VXZ)
iPath Series B S&P 500 VIX MidTerm Futures ETN (VXZ) Opzioni

iPath Series B S&P 500 VIX MidTerm Futures ETN (VXZ)

54,65

1,88

( 3,56% )

Aggiornato: 20:01:29

Ritardato di 15 minuti

VXZ Flusso Di Opzioni

Call

Strike	Denaro	Lettera	Ultimo Prezzo	Punto Medio	Var	Var %	Volume	INT APERTO	Ora Ultimo Ordine
45,00	7,50	11,10	7,12	9,30	0,00	0,00 %	0	1	-
46,00	6,50	9,70	0,00	8,10	0,00	0,00 %	0	0	-
47,00	5,50	9,10	5,09	7,30	0,00	0,00 %	0	43	-
48,00	4,50	8,10	5,72	6,30	0,37	6,92 %	5	146	15:32:28
49,00	3,40	6,90	5,20	5,15	2,47	90,48 %	6	2	16:43:47
50,00	2,50	6,10	0,00	4,30	0,00	0,00 %	0	0	-
51,00	1,55	4,60	1,81	3,075	0,00	0,00 %	0	1	-
52,00	0,55	4,90	2,85	2,725	0,15	5,56 %	5	133	15:32:28
53,00	0,05	3,30	1,68	1,675	0,00	0,00 %	0	54	-
54,00	0,05	2,70	0,00	1,375	0,00	0,00 %	0	0	-
55,00	1,00	2,05	0,87	1,525	0,00	0,00 %	0	30	-
56,00	0,70	1,80	1,15	1,25	-0,28	-19,58 %	5	132	15:32:28
57,00	0,05	2,00	0,50	1,025	0,00	0,00 %	0	53	-
58,00	0,40	2,10	3,95	1,25	0,00	0,00 %	0	3	-
59,00	0,30	1,90	3,73	1,10	0,00	0,00 %	0	4	-
60,00	0,25	1,75	1,10	1,00	0,00	0,00 %	0	10	-
61,00	0,20	1,70	1,30	0,95	0,00	0,00 %	0	2	-
62,00	0,15	1,60	1,25	0,875	0,00	0,00 %	0	4	-
63,00	0,10	1,55	1,25	0,825	0,00	0,00 %	0	4	-
65,00	0,10	0,60	2,05	0,35	0,00	0,00 %	0	6	-

Il tuo punto di riferimento per quotazioni in tempo reale, idee e discussioni live.

Put

Strike	Denaro	Lettera	Ultimo Prezzo	Punto Medio	Var	Var %	Volume	INT APERTO	Ora Ultimo Ordine
45,00	0,38	1,80	0,38	1,09	0,00	0,00 %	1	19	15:27:13
46,00	0,00	0,75	0,00	0,00	0,00	0,00 %	0	0	-
47,00	0,45	0,75	0,45	0,60	0,00	0,00 %	0	2	-
48,00	0,87	1,80	0,33	1,335	-0,54	-62,07 %	21	85	15:31:58
49,00	0,10	0,75	0,38	0,425	0,00	0,00 %	0	19	-
50,00	0,25	1,85	0,84	1,05	0,44	110,00 %	1	1	15:27:13
51,00	0,05	0,70	1,20	0,375	0,00	0,00 %	0	34	-
52,00	0,20	0,90	0,53	0,55	-0,55	-50,93 %	21	54	15:31:58
53,00	0,50	2,40	0,84	1,45	-0,73	-46,50 %	1	69	15:27:13
54,00	0,05	2,90	0,00	1,475	0,00	0,00 %	0	0	-
55,00	0,10	2,40	0,00	1,25	0,00	0,00 %	0	0	-
56,00	1,95	3,20	3,21	2,575	-0,59	-15,53 %	21	53	15:31:58
57,00	1,50	5,10	4,71	3,30	0,00	0,00 %	0	37	-
58,00	2,20	6,10	5,00	4,15	-1,05	-17,36 %	1	6	15:27:13
59,00	3,10	6,80	9,00	4,95	0,00	0,00 %	0	1	-
60,00	4,40	7,60	10,00	6,00	0,00	0,00 %	0	1	-
61,00	4,80	8,50	0,00	6,65	0,00	0,00 %	0	0	-
62,00	5,90	9,40	0,00	7,65	0,00	0,00 %	0	0	-
63,00	6,90	10,30	12,80	8,60	0,00	0,00 %	0	1	-
65,00	8,80	12,30	0,00	10,55	0,00	0,00 %	0	0	-

Più Attivi
% Guadagnanti
% Perdenti

Simbolo	Prezzo	Vol.
PRTGPortage Biotech Inc	US$ 9,43 (100,21%)	27,95M
LXRXLexicon Pharmaceuticals Inc	US$ 0,59475 (71,10%)	381,7M
DBVTDBV Technologies SA	US$ 6,09 (55,75%)	20,55M
LXEHLixiang Education Holding Company Ltd	US$ 18,00 (35,03%)	195,96k
SNSESensei Biotherapeutics Inc	US$ 0,5634 (30,78%)	142,39M
STSSSharps Technology Inc	US$ 0,0397 (-74,00%)	186,01M
MISTMilestone Pharmaceuticals Inc	US$ 0,8934 (-60,29%)	31,74M
ICONIcon Energy Corporation	US$ 0,0505 (-49,50%)	22,4M
XTIAXTI Aerospace Inc	US$ 1,255 (-48,98%)	1,52M
LGMKLogicMark Inc	US$ 0,0261 (-48,82%)	119,22M
LXRXLexicon Pharmaceuticals Inc	US$ 0,59475 (71,10%)	381,7M
STSSSharps Technology Inc	US$ 0,0397 (-74,00%)	186,01M
TSLLDirexion Daily TSLA Bull 2X Trust ETF	US$ 9,855 (-7,20%)	175,81M
NVDANVIDIA Corporation	US$ 110,1899 (-1,11%)	172,3M
SNSESensei Biotherapeutics Inc	US$ 0,5634 (30,78%)	142,39M

researcher59

researcher59 4 minuti fa

PSIX -3.60 to 25.65, it's on my watchlist for potential purchase, but the way it's dropping it might be under $20 by late next week .....

BBANBOB

BBANBOB 4 minuti fa

JHD

"" WMI they would have needed to be disclosed in BK proceedings""

IF it is NOT A DIRECTLY HELD/OWNED in title as an asset of the debtor it can not be used in BK court or even spoken about, as it is OUTSIDE of the reach and has no bearing on the BK case, as it is/wa

hondaboost

hondaboost 4 minuti fa

NKLAQ, (was $346), R&R, may run to dollar-land.

StayHumble

StayHumble 4 minuti fa

💹wow✅$HCMC Stock Dividend+✅💹BUYBACK💹 ✅ 💹

-A buyback of up to $5M of $HCMC common stock.

-A spinoff of certain HCMC assets into a new publicly traded company

-A stock dividend to $HCMC shareholders of th

dexprs

dexprs 4 minuti fa

People have a higher income, but due to worries about what may happen tomorrow they do not spend. This could greatly affect earnings.

gains4us

gains4us 5 minuti fa

Since they keep the SS stable that is a good thing i guess?!

pumper_stumper

pumper_stumper 5 minuti fa

DD challenge: Koos chose ClinDatrix to do the Phase 1 trial for their 9 year mothballed "miracle drug" that he suddenly decided to resurrect.

Any good quality proper due diligence on ClinDatrix would show why these 2 pathetic companies are perfect for each other. Remember, this

splintered sunlight

splintered sunlight 5 minuti fa

Who is selling the snot out of KTRL?

JP313

JP313 5 minuti fa

Quote Kevin Garnet > anything possible

dexprs

dexprs 6 minuti fa

It is never a good idea to think that a Recession is OK for the greater good results to come later. No Administration ever before took Recession lightly, of course if you have total power to do as you wish and control the people inspite of lower approval numbers, why care at all.

kenyboy

kenyboy 7 minuti fa

Mr. Ralphey:
Did you sell all your shares or what is the plan as you are very savy?

JP313

JP313 7 minuti fa

Ok and, looks good until they go to the bathroom & take a dump

CommodityCoverage

CommodityCoverage 7 minuti fa

Clinical-stage biotech company Thiogenesis Therapeutics Corp. (TTI.v TTIPF) has received final approval from the European Medicines Agency to initiate a Phase 2 clinical trial of its lead drug, TTI-0102, for MELAS—a rare, progressive mitochondrial disorder with no approved treatments.

$7.00 or Nothing

$7.00 or Nothing 7 minuti fa

Read the transcript It says by April

Grey_Ghost

Grey_Ghost 8 minuti fa

If they have something to say, I'd think that they'd want to release it prior to the weekend. It would allow their current, primary investor base (retail) plenty of time to digest and disseminate. My sense is that they're feeling the heat from a portion of that base and, again, if they have somethin

Monroe1

Monroe1 8 minuti fa

About Merck’s research in women’s cancers

Merck is advancing research aimed at expanding treatment options for certain breast and gynecologic (ovarian, cervical and endometrial) cancers, with a goal of improving outcomes for more patients affected by these diseases. Breast cancer and

EmpressMonk25

EmpressMonk25 9 minuti fa

Is it the same kind of red seen the day before Dec 3rd, with the same fool's claiming Humbl was dead and the coffin had been nailed shut? 🤣

ListenToTheTrees

ListenToTheTrees 9 minuti fa

Just because you add FACT at the end of your opinion, doesn't make it so. You are intentionally leaving out market details and situations like convertible notes and toxic sellers vs B holders dumping. I know it hurts, but its true.

rbtree

rbtree 10 minuti fa

good things are coming very soon

Define soon.... how about by the year 3510.... if not by then, what then?

Enjoy your fantasy.

jasmin8192

jasmin8192 11 minuti fa

It would be great to get back close to a dollar--even better if above. At least there is some movement. I was a bit concerned at 3 cents as that could have signaled something very dire for all of us.

Have a great weekend. Getting out of my office a bit early for a change.

BigBadWolf

BigBadWolf 11 minuti fa

Becoming obvious as to my Controllability over @JustaLilNoise & @BubbyGotTaken both Painfully it seems is on full display as well & for all to see.

Our wannabe saviors are here… $RDARubberBoots required for either side of the river. Usually happy in my flip flops yet damn glad I’

janice shell

janice shell 11 minuti fa

https://www.youtube.com/watch?v=_c-vn5zTDqo

wiwineguy

wiwineguy 11 minuti fa

Beentheredonelqmt

Beentheredonelqmt 11 minuti fa

.077 from .125 is pulling comments from the 'Facts Handbook' You guys just can't admit you were wrong. IMO lqmt is .05 not .10 and today is a further indication of the trend downward.

iPath Series B S&P 500 V...

Apple Hospitality REIT

Novelion Therapeutics

Societe Generale Effekten

Vontobel Financial Produ...

Vontobel Financial Produ...

Sth.e.wtr.3h%db

INTESA SANPAOLO

Delayed Upgrade Clock

Assistenza: support@advfn.it

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni